Form 4: Modular Medical Director Sheibley Receives Stock Options

Philip Brent Sheibley, a director at Modular Medical, Inc., was granted options to purchase 7,500 shares of common stock on September 30, 2024.

Summary

• Philip Brent Sheibley, a director at Modular Medical, Inc., filed a Form 4 indicating a change in beneficial ownership.
• On September 30, 2024, Sheibley was granted an option to purchase 7,500 shares of Modular Medical's common stock at an exercise price of $2.28.
• The option was fully vested and exercisable on the grant date and expires on September 30, 2034.
• The transaction was made in accordance with the Issuer's Outside Director Compensation Plan.

Sentiment

Score: 7

Explanation: The document indicates standard director compensation practices, which is generally viewed neutrally to positively as it aligns director interests with shareholders.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The options are fully vested immediately, incentivizing the director to contribute to the company's success from day one.

Industry Context

Stock options are a common form of compensation for directors, aligning their interests with shareholders and incentivizing company growth.

Comparison to Industry Standards

• Director compensation packages vary widely across the industry, but stock options are a standard component, particularly for smaller companies.
• Comparing the size of this option grant to similar companies in the medical device sector would provide context on its relative value.

Stakeholder Impact

• Shareholders may view the option grant positively as it incentivizes the director to increase shareholder value.
• The director benefits from the potential upside of the company's stock price.

Key Dates